Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus
Mikail Dogan, Lina Kozhaya, Lindsey Placek, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 125

Showing 1-25 of 125 citing articles:

Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses — are we our own worst enemy?
Lok-Yin Roy Wong, Stanley Perlman
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 47-56
Open Access | Times Cited: 162
Immune responses during COVID-19 infection
Cléa Melenotte, Aymeric Silvin, Anne-Gaëlle Goubet, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 146
Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice
Natalie Yan‐Lin Pang, Alexander Shao‐Rong Pang, Vincent Chow, et al.
Military Medical Research (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 132
The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals
Carlos A. Cañas
Medical Hypotheses (2020) Vol. 145, pp. 110345-110345
Open Access | Times Cited: 101
Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro
Martina Morokutti-Kurz, Maria Fröba, Philipp Graf, et al.
PLoS ONE (2021) Vol. 16, Iss. 2, pp. e0237480-e0237480
Open Access | Times Cited: 91
Evaluation and Comparison of Serological Methods for COVID-19 Diagnosis
Fanwu Gong, Hua-Xing Wei, Qiangsheng Li, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 83
Longitudinal analysis of clinical serology assay performance and neutralising antibody levels in COVID19 convalescents
Frauke Muecksch, Helen Wise, Becky Batchelor, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 76
Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy
T. Alp İkizler, P Coates, Brad H. Rovin, et al.
Kidney International (2021) Vol. 99, Iss. 6, pp. 1275-1279
Open Access | Times Cited: 67
Pfizer-BioNTech and Sinopharm: A Comparative Study on Post-Vaccination Antibody Titers
Rami Alqassieh, Aiman Suleiman, Sami A. Abu‐Halaweh, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1223-1223
Open Access | Times Cited: 66
SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people
Tara M. Narowski, Kristin Raphel, Lily E. Adams, et al.
Cell Reports (2022) Vol. 38, Iss. 5, pp. 110336-110336
Open Access | Times Cited: 49
Estimating the Neutralizing Effect and Titer Correlation of Semi-Quantitative Anti-SARS-CoV-2 Antibody Immunoassays
Beomki Lee, Jae‐Hoon Ko, Ji‐Ho Park, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 37
Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents
Carolina Garrido, Jillian H. Hurst, Cynthia G. Lorang, et al.
JCI Insight (2021) Vol. 6, Iss. 17
Open Access | Times Cited: 49
Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacities
María G. Noval, Maria E. Kaczmarek, Akiko Koide, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 46
Autoimmune Encephalitis in COVID-19 Infection: Our Experience and Systematic Review of the Literature
Adina Stoian, M Stoian, Zoltán Bajkó, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 774-774
Open Access | Times Cited: 36
The anti–SARS-CoV-2 monoclonal antibody bamlanivimab minimally affects the endogenous immune response to COVID-19 vaccination
Robert J. Benschop, Jay Tuttle, Lin Zhang, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 655
Open Access | Times Cited: 29
Immunology of Multisystem Inflammatory Syndrome after COVID-19 in Children: A Review of the Current Evidence
Filippos Filippatos, Elizabeth‐Barbara Tatsi, Athanasios Michos
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5711-5711
Open Access | Times Cited: 18
Veterinary systems biology for bridging the phenotype–genotype gap via computational modeling for disease epidemiology and animal welfare
Rajesh Kumar Pathak, Jun‐Mo Kim
Briefings in Bioinformatics (2024) Vol. 25, Iss. 2
Open Access | Times Cited: 5
Impact of immunosuppressive regimens on antibody response after COVID-19 vaccination among Thai kidney transplant recipients
Nuttasith Larpparisuth, Kritsada Pongsakornkullachart, Nartsiri Ratchawang, et al.
Heliyon (2025) Vol. 11, Iss. 3, pp. e42291-e42291
Open Access
A Live-Cell Imaging-Based Fluorescent SARS-CoV-2 Neutralization Assay by Antibody-Mediated Blockage of Receptor Binding Domain-ACE2 Interaction
Jorge L. Arias-Arias, Laura Monturiol‐Gross, Eugenia Corrales‐Aguilar
BioTech (2025) Vol. 14, Iss. 1, pp. 10-10
Open Access
Evidence of rapid rise in population immunity from SARS-CoV-2 subclinical infections through pre-vaccination serial serosurveys in Pakistan
Junaid Iqbal, Zahra Hasan, Atif Habib, et al.
Journal of Global Health (2025) Vol. 15
Open Access
Antibody Responses to SARS-CoV-2 After Infection or Vaccination in Children and Young Adults With Inflammatory Bowel Disease
Joelynn Dailey, Lina Kozhaya, Mikail Dogan, et al.
Inflammatory Bowel Diseases (2021) Vol. 28, Iss. 7, pp. 1019-1026
Open Access | Times Cited: 37
The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein
Xuemin Chen, Christina A. Rostad, Larry J. Anderson, et al.
Virology (2021) Vol. 559, pp. 1-9
Open Access | Times Cited: 34
Neutralizing Antibody Responses to SARS-CoV-2 in Recovered COVID-19 Patients Are Variable and Correlate With Disease Severity and Receptor-Binding Domain Recognition
Agnieszka Katarzyna Macioła, Massimo La Raja, Monia Pacenti, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
IgA2 Antibodies against SARS-CoV-2 Correlate with NET Formation and Fatal Outcome in Severely Diseased COVID-19 Patients
Léonie A. N. Staats, Hella Pfeiffer, Jasmin Knopf, et al.
Cells (2020) Vol. 9, Iss. 12, pp. 2676-2676
Open Access | Times Cited: 33
A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection
Zhujun Ao, Maggie Jing Ouyang, Titus Abiola Olukitibi, et al.
Journal of Virology (2022) Vol. 96, Iss. 18
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top